Review
Long-Term Outcomes With Nivolumab Plus Ipilimumab or Nivolumab Alone Versus Ipilimumab in Patients With Advanced Melanoma.
Wolchok JD, Chiarion-Sileni V, Gonzalez R, Grob JJ, Rutkowski P et al.
ReviewJournal of clinical oncology : official journal of the American Society of Clinical Oncology2022
Research Facts
Long-Term Outcomes With Nivolumab Plus Ipilimumab or Nivolumab Alone Versus Ipilimumab in Patients With Advanced Melanoma.
Wolchok JD, Chiarion-Sileni V, Gonzalez R, Grob JJ, Rutkowski P et al.
Review · Moderate · 2022
Findings

PubMed study on Mica in cosmetics/dermatology

Design
Review
Evidence
Moderate
Journal
Journal of clinical oncology : official journal of the American Society of Clinical Oncology